Medical News

RSS

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

Kinexus Bioinformatics Corporation announced the commercial release of its novel Protein Kinase Microarray with 200 recombinant human protein kinases for screening. The microarray has wide utility including applications for drug target counter screening, to identify novel kinase substrates, establish kinase antibody specificities, and for the discovery and testing of protein kinase-protein and protein kinase-compound interactions.

10 Feb 2010

DMC recommends JV to continue enrolling patients in Phase III clinical trial of StemEx

The Gamida Cell-Teva Joint Venture (JV) announced today that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx (called ExCell) and has recommended that the JV continue to enroll patients in this study.

10 Feb 2010

NeuroMetrix announces 2009 fourth quarter financial results

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009.

10 Feb 2010

Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug

Biovail Corporation today announced that its subsidiary, Biovail Laboratories International SRL (BLS), has entered into a collaboration and license agreement with Alexza Pharmaceuticals, Inc.

10 Feb 2010

BioClinica reports financial results for quarter and year ended December 31, 2009

BioClinica™, Inc., a global provider of clinical trial services, today announced its financial results for the quarter and year ended December 31, 2009. The operating results of Phoenix Data Systems (“PDS”) are included in the financial results following the acquisition of PDS that was completed March 24, 2008.

From Clario 10 Feb 2010

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 second quarter, ended December 31, 2009.

10 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

DTM programs increase adherence to injectable medications and treatment persistence in MS patients

A new study reveals that multiple sclerosis (MS) patients enrolled in a seven-month disease therapy management (DTM) program show greater adherence to injectable MS medications and treatment persistence than patients who receive injectable MS medications through a community pharmacy.

10 Feb 2010

ISR’s report identifies challenges faced by industry while recruiting participants in clinical trails

Industry Standard Research (ISR Reports) today announced the launch of a substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.

10 Feb 2010

Contraceptive sex education and 'empowerment' for ten-year-old children

International Planned Parenthood Foundation's recently released report, "Stand and Deliver: Sex, Health and Young People in the 21st Century," advocates policies that jeopardize the well-being of children's health, the importance of parents and the moral values of our society, Family Research Council said today.

10 Feb 2010

Researchers find differences in the biology of lung cancer between men and women

An analysis of genetic and clinical data for nearly 800 patients with non-small cell lung cancer has identified differences in genetic characteristics that are associated with age and sex specific patterns of increased or decreased recurrence-free survival, according to a study in the February 10 issue of JAMA.

10 Feb 2010

ONA warns nursing cuts may result in longer wait times for cancer patients

The Ontario Nurses' Association (ONA) is warning that London-area cancer patients will face longer wait times as London Health Sciences Centre cuts five of its 22 full-time and four of its part-time front-line primary care nurses providing outpatient cancer program care.

10 Feb 2010

MEDecision completes latest round of interoperability tests with other leading EHR vendors

MEDecision, Inc., a leading provider of collaborative healthcare management solutions, today announced the successful completion of its latest round of interoperability tests with other leading electronic health record (EHR) vendors at the 11th Annual Integrating the Healthcare Enterprise (IHE) North America Connectathon recently held in Chicago.

10 Feb 2010

Mapping of all fragile sites of yeast S.cerevisiae may lead to better understanding of cancer development

The research group of Dr. Fran-ois Robert, a researcher at the Institut de recherches cliniques de Montr-al (IRCM), in collaboration with the team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute and University of Toronto) accomplished a technical breakthrough: they mapped all the fragile sites of a living organism, the budding yeast Saccharomyces cerevisiae. The method used by the researchers can be applied to humans. This study has been published online today in the scientific journal Nature Structural and Molecular Biology.

10 Feb 2010

Provectus Pharmaceuticals publishes article on novel treatment for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces the publication of an article, entitled “A novel treatment for metastatic melanoma with intralesional rose bengal and radiotherapy: a case series," authored by Dr. Matthew C. Foote, Dr. Bryan H. Burmeister, Janine Thomas, and Dr. B. Mark Smithers, in the current issue of the peer-reviewed journal, Melanoma Research (20(1):48-51, February 2010).

10 Feb 2010

Athena Cosmetics launches RevitaBrow to revitalize eyebrows

Beautifully shaped eyebrows frame the face, define the eyes and are regarded by makeup artists as an essential element to a finished look. Now, beautiful brows will be easier than ever to achieve with the help of RevitaBrow! RevitaBrow is the newest product to be introduced from Athena Cosmetics, Inc., maker of RevitaLash, the number one cosmetic eyelash conditioner.

10 Feb 2010

SafeStitch Medical's AMID Stapler receives European CE Mark

SafeStitch Medical, Inc. announced today that it has received CE Mark authorization to commercialize its AMID StaplerTM in the European Economic Community. The new stapler is to be used for fixation of mesh in the repair of hernia defects and also for the approximation of tissues, including skin. The AMID Stapler™ is the first surgical stapler designed specifically for use in inguinal hernia repairs using the Lichtenstein method, in which mesh is implanted for reinforcement. SafeStitch announced in November 2009 that it had received 510(k) clearance from the Food and Drug Administration for sale of the AMID StaplerTM in the U.S. market.

10 Feb 2010

First Edition: February 10, 2010

Today's headlines indicate that health reform is among the issues on the table as President Obama meets with Republican leaders and seeks to 'bridge the partisan divide.'

10 Feb 2010

Findings suggest AP patients lack the ability to process faces as a whole

In a new study published in the March 2010 issue of Elsevier's Cortex, researchers have found that the condition is linked to an inability to process faces as a whole, or holistically.

10 Feb 2010

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Age-related gaps in care and outcomes for stroke patients are diminishing as hospitals improve adherence to evidence-based treatments of the American Heart Association/American Stroke Association's Get With The Guidelines–Stroke initiative, according to a new study in Circulation: Journal of the American Heart Association.

10 Feb 2010

Medical News

Kinexus Bioinformatics announces the commercial release of Protein Kinase Microarray

DMC recommends JV to continue enrolling patients in Phase III clinical trial of StemEx

NeuroMetrix announces 2009 fourth quarter financial results

Biovail and Alexza Pharmaceuticals sign collaboration and license agreement for anti-agitation drug

BioClinica reports financial results for quarter and year ended December 31, 2009

Second-quarter fiscal 2010 results announced by Bioniche Life Sciences

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

DTM programs increase adherence to injectable medications and treatment persistence in MS patients

ISR’s report identifies challenges faced by industry while recruiting participants in clinical trails

Contraceptive sex education and 'empowerment' for ten-year-old children

Researchers find differences in the biology of lung cancer between men and women

ONA warns nursing cuts may result in longer wait times for cancer patients

MEDecision completes latest round of interoperability tests with other leading EHR vendors

Mapping of all fragile sites of yeast S.cerevisiae may lead to better understanding of cancer development

Provectus Pharmaceuticals publishes article on novel treatment for metastatic melanoma

Athena Cosmetics launches RevitaBrow to revitalize eyebrows

SafeStitch Medical's AMID Stapler receives European CE Mark

First Edition: February 10, 2010

Findings suggest AP patients lack the ability to process faces as a whole

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Latest News